{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:19:42Z","timestamp":1772806782717,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["U01FD005875"],"award-info":[{"award-number":["U01FD005875"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s12020-020-02211-w","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T22:10:32Z","timestamp":1580249432000},"page":"336-348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Generic levothyroxine initiation and substitution among Medicare and Medicaid populations: a new user cohort study"],"prefix":"10.1007","volume":"68","author":[{"given":"Nan","family":"Huo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Ullah Mishuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilene","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zippora","family":"Kiptanui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah K.","family":"Dutcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4624-9963","authenticated-orcid":false,"given":"Jingjing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,28]]},"reference":[{"key":"2211_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldr030","volume":"99","author":"MP Vanderpump","year":"2011","unstructured":"M.P. Vanderpump, The epidemiology of thyroid disease. Br. Med. Bull. 99, 39\u201351 (2011). https:\/\/doi.org\/10.1093\/bmb\/ldr030","journal-title":"Br. Med. Bull."},{"issue":"12","key":"2211_CR2","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1089\/thy.2006.0235","volume":"17","author":"Y Aoki","year":"2007","unstructured":"Y. Aoki, R.M. Belin, R. Clickner, R. Jeffries, L. Phillips, K.R. Mahaffey, Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid 17(12), 1211\u20131223 (2007). https:\/\/doi.org\/10.1089\/thy.2006.0235","journal-title":"Thyroid"},{"issue":"5","key":"2211_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1530\/eje-13-0459","volume":"169","author":"BO Asvold","year":"2013","unstructured":"B.O. Asvold, L.J. Vatten, T. Bjoro, Changes in the prevalence of hypothyroidism: the HUNT study in Norway. Eur. J. Endocrinol. 169(5), 613\u2013620 (2013). https:\/\/doi.org\/10.1530\/eje-13-0459","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"2211_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","volume":"87","author":"JG Hollowell","year":"2002","unstructured":"J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87(2), 489\u2013499 (2002). https:\/\/doi.org\/10.1210\/jcem.87.2.8182","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2211_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.4158\/1934-2403-8.6.457","volume":"8","author":"HJ Baskin","year":"2002","unstructured":"H.J. Baskin, R.H. Cobin, D.S. Duick, H. Gharib, R.B. Guttler, M.M. Kaplan, R.L. Segal, American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr. Pract. 8(6), 457\u2013469 (2002)","journal-title":"Endocr. Pract."},{"issue":"6","key":"2211_CR6","doi-asserted-by":"publisher","first-page":"988","DOI":"10.4158\/ep12280.gl","volume":"18","author":"JR Garber","year":"2012","unstructured":"J.R. Garber, R.H. Cobin, H. Gharib, J.V. Hennessey, I. Klein, J.I. Mechanick, R. Pessah-Pollack, P.A. Singer, K.A. Woeber, Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr. Pract. 18(6), 988\u20131028 (2012). https:\/\/doi.org\/10.4158\/ep12280.gl","journal-title":"Endocr. Pract."},{"key":"2211_CR7","unstructured":"AACE, TES, and ATA joint position statement on the use and interchangeability of thyroxine products. Thyroxine Products Joint Position Statement. https:\/\/www.thyroid.org\/thyroxine-products-joint-position-statement\/. (2004)"},{"key":"2211_CR8","doi-asserted-by":"publisher","unstructured":"American Thyroid Association, The Endocrine Society and American Association of Clinical Endocrinologists. Joint statement on the U.S. Food and Drug Administration\u2019s decision regarding bioequivalence of levothyroxine sodium. Thyroid. 14(7), 486 (2004). https:\/\/doi.org\/10.1089\/1050725041517138","DOI":"10.1089\/1050725041517138"},{"key":"2211_CR9","doi-asserted-by":"crossref","unstructured":"S. Benvenga, A. Carl\u00e9, Levothyroxine formulations: pharmacological and clinical implications of generic substitution. Adv. Ther. 36(Suppl 2), 59\u201371 (2019)","DOI":"10.1007\/s12325-019-01079-1"},{"issue":"6","key":"2211_CR10","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1210\/jc.2014-1046","volume":"99","author":"HB Burch","year":"2014","unstructured":"H.B. Burch, K.D. Burman, D.S. Cooper, J.V. Hennessey, A 2013 survey of clinical practice patterns in the management of primary hypothyroidism. J. Clin. Endocrinol. Metab. 99(6), 2077\u20132085 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1046","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2211_CR11","unstructured":"GPhA, Generic Drug Savings in the U.S. Seventh Annual Edition. (GPhA, 2015). http:\/\/www.gphaonline.org\/media\/wysiwyg\/PDF\/GPhA_Savings_Report_2015.pdf"},{"issue":"20","key":"2211_CR12","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJMp078193","volume":"357","author":"RG Frank","year":"2007","unstructured":"R.G. Frank, The ongoing regulation of generic drugs. N. Engl. J. Med. 357(20), 1993\u20131996 (2007). https:\/\/doi.org\/10.1056\/NEJMp078193","journal-title":"N. Engl. J. Med."},{"key":"2211_CR13","unstructured":"(AAM) TAfAM. Generic Drug Access & Savings Report. (2018). https:\/\/accessiblemeds.org\/sites\/default\/files\/2018_aam_generic_drug_access_and_savings_report.pdf"},{"issue":"7","key":"2211_CR14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.sapharm.2017.08.001","volume":"14","author":"JN Howard","year":"2018","unstructured":"J.N. Howard, I. Harris, G. Frank, Z. Kiptanui, J. Qian, R. Hansen, Influencers of generic drug utilization: a systematic review. Res. Soc. Adm. Pharm. 14(7), 619\u2013627 (2018). https:\/\/doi.org\/10.1016\/j.sapharm.2017.08.001","journal-title":"Res. Soc. Adm. Pharm."},{"key":"2211_CR15","unstructured":"B.R. Troy, The 10 most-prescribed and top-selling medications. (2015). https:\/\/www.webmd.com\/drug-medication\/news\/20150508\/most-prescribed-top-selling-drugs"},{"issue":"8","key":"2211_CR16","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1177\/1060028017705393","volume":"51","author":"RJ Romanelli","year":"2017","unstructured":"R.J. Romanelli, V. Nimbal, S.K. Dutcher, X. Pu, J.B. Segal, Provider and patient determinants of generic levothyroxine prescribing: an electronic health records-based study. Ann. Pharmacother. 51(8), 640\u2013648 (2017). https:\/\/doi.org\/10.1177\/1060028017705393","journal-title":"Ann. Pharmacother."},{"key":"2211_CR17","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","volume":"51","author":"MA Raebel","year":"2013","unstructured":"M.A. Raebel, J. Schmittdiel, A.J. Karter, J.L. Konieczny, J.F. Steiner, Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med. Care 51, S11\u2013S21 (2013). https:\/\/doi.org\/10.1097\/MLR.0b013e31829b1d2a","journal-title":"Med. Care"},{"key":"2211_CR18","unstructured":"US Census Bureau 2010 ZIP Code Tabulation Area (ZCTA) Relationship File Layouts and Contents. Geography. (US Census Bureau). https:\/\/www.census.gov\/geo\/maps-data\/data\/zcta_rel_layout.html. Accessed 21 Aug 2018"},{"issue":"16","key":"2211_CR19","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1001\/jama.293.16.1995","volume":"293","author":"RL Kravitz","year":"2005","unstructured":"R.L. Kravitz, R.M. Epstein, M.D. Feldman, C.E. Franz, R. Azari, M.S. Wilkes, L. Hinton, P. Franks, Influence of patients\u2019 requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA 293(16), 1995\u20132002 (2005). https:\/\/doi.org\/10.1001\/jama.293.16.1995","journal-title":"JAMA"},{"issue":"9","key":"2211_CR20","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1111\/jgs.12399","volume":"61","author":"JJ Gagne","year":"2013","unstructured":"J.J. Gagne, J.M. Polinski, A.S. Kesselheim, N.K. Choudhry, D. Hutchins, O.S. Matlin, A. Tong, W.H. Shrank, Patterns and predictors of generic narrow therapeutic index drug use among older adults. J. Am. Geriatrics Soc. 61(9), 1586\u20131591 (2013). https:\/\/doi.org\/10.1111\/jgs.12399","journal-title":"J. Am. Geriatrics Soc."},{"issue":"7","key":"2211_CR21","first-page":"1383","volume":"29","author":"WH Shrank","year":"2010","unstructured":"W.H. Shrank, N.K. Choudhry, J. Agnew-Blais, A.D. Federman, J.N. Liberman, J. Liu, A.S. Kesselheim, M.A. Brookhart, Fischer MAJHa, State generic substitution laws can lower drug outlays under. Medicaid 29(7), 1383\u20131390 (2010)","journal-title":"Medicaid"},{"issue":"4","key":"2211_CR22","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/1475-6773.00162","volume":"38","author":"MA Fischer","year":"2003","unstructured":"M.A. Fischer, J. Avorn, Economic consequences of underuse of generic drugs: evidence from medicaid and implications for prescription drug benefit plans. Health Serv. Res. 38(4), 1051\u20131064 (2003). https:\/\/doi.org\/10.1111\/1475-6773.00162","journal-title":"Health Serv. Res."},{"key":"2211_CR23","doi-asserted-by":"publisher","first-page":"E142","DOI":"10.5888\/pcd9.120010","volume":"9","author":"K Sewell","year":"2012","unstructured":"K. Sewell, S. Andreae, E. Luke, M.M. Safford, Perceptions of and barriers to use of generic medications in a rural African American population, Alabama, 2011. Preventing Chronic Dis. 9, E142 (2012). https:\/\/doi.org\/10.5888\/pcd9.120010","journal-title":"Preventing Chronic Dis."},{"issue":"2","key":"2211_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.pec.2008.07.012","volume":"73","author":"A Iosifescu","year":"2008","unstructured":"A. Iosifescu, E.A. Halm, T. McGinn, A.L. Siu, A.D. Federman, Beliefs about generic drugs among elderly adults in hospital-based primary care practices. Patient Educ. Couns. 73(2), 377\u2013383 (2008). https:\/\/doi.org\/10.1016\/j.pec.2008.07.012","journal-title":"Patient Educ. Couns."},{"issue":"5","key":"2211_CR25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1345\/aph.1R028","volume":"46","author":"AL Hulbert","year":"2012","unstructured":"A.L. Hulbert, N.A. Pilch, D.J. Taber, K.D. Chavin, P.K. Baliga, Generic immunosuppression: deciphering the message our patients are receiving. Ann. Pharmacother. 46(5), 671\u2013677 (2012). https:\/\/doi.org\/10.1345\/aph.1R028","journal-title":"Ann. Pharmacother."},{"issue":"2","key":"2211_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/01.mlr.0000250293.24939.2e","volume":"45","author":"AD Federman","year":"2007","unstructured":"A.D. Federman, E.A. Halm, A.L. Siu, Use of generic cardiovascular medications by elderly medicare beneficiaries receiving generalist or cardiologist care. Med. Care 45(2), 109\u2013115 (2007). https:\/\/doi.org\/10.1097\/01.mlr.0000250293.24939.2e","journal-title":"Med. Care"},{"issue":"8","key":"2211_CR27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/01.mlr.0000078145.41828.3e","volume":"41","author":"R Tamblyn","year":"2003","unstructured":"R. Tamblyn, P. McLeod, J.A. Hanley, N. Girard, J. Hurley, Physician and practice characteristics associated with the early utilization of new prescription drugs. Med Care 41(8), 895\u2013908 (2003). https:\/\/doi.org\/10.1097\/01.mlr.0000078145.41828.3e","journal-title":"Med Care"},{"issue":"5","key":"2211_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.7326\/0003-4819-124-5-199603010-00007","volume":"124","author":"SH Kaplan","year":"1996","unstructured":"S.H. Kaplan, S. Greenfield, B. Gandek, W.H. Rogers, J.E. Ware Jr, Characteristics of physicians with participatory decision-making styles. Ann. Intern. Med. 124(5), 497\u2013504 (1996)","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"2211_CR29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1001\/jama.1997.03540280088045","volume":"277","author":"DL Roter","year":"1997","unstructured":"D.L. Roter, M. Stewart, S.M. Putnam, M. Lipkin Jr, W. Stiles, T.S. Inui, Communication patterns of primary care physicians. JAMA 277(4), 350\u2013356 (1997)","journal-title":"JAMA"},{"issue":"1","key":"2211_CR30","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/j.whi.2012.10.002","volume":"23","author":"A Omojasola","year":"2013","unstructured":"A. Omojasola, B. Gor, L. Jones, Perceptions of generic drug discount programs among low-income women: a qualitative study. Womens Health issues 23(1), e55\u2013e60 (2013). https:\/\/doi.org\/10.1016\/j.whi.2012.10.002","journal-title":"Womens Health issues"},{"key":"2211_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1476-072x-11-48","volume":"11","author":"P Amstislavski","year":"2012","unstructured":"P. Amstislavski, A. Matthews, S. Sheffield, A.R. Maroko, J. Weedon, Medication deserts: survey of neighborhood disparities in availability of prescription medications. Int. J. Health Geogr. 11, 48 (2012). https:\/\/doi.org\/10.1186\/1476-072x-11-48","journal-title":"Int. J. Health Geogr."},{"issue":"5","key":"2211_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/MED.0000000000000003","volume":"20","author":"S Benvenga","year":"2013","unstructured":"S. Benvenga, When thyroid hormone replacement is ineffective? Curr. Opin. Endocrinol. Diabetes, Obes. 20(5), 467\u2013477 (2013). https:\/\/doi.org\/10.1097\/MED.0000000000000003","journal-title":"Curr. Opin. Endocrinol. Diabetes, Obes."},{"issue":"1","key":"2211_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1001\/jamainternmed.2013.11312","volume":"174","author":"PN Taylor","year":"2014","unstructured":"P.N. Taylor, A. Iqbal, C. Minassian, A. Sayers, M.S. Draman, R. Greenwood, W. Hamilton, O. Okosieme, V. Panicker, S.L. Thomas, Falling threshold for treatment of borderline elevated thyrotropin levels\u2013balancing benefits and risks: evidence from a large community-based study. JAMA Intern. Med. 174(1), 32\u201339 (2014)","journal-title":"JAMA Intern. Med."},{"issue":"2","key":"2211_CR34","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12020-013-9886-1","volume":"44","author":"P dos Santos Vig\u00e1rio","year":"2013","unstructured":"P. dos Santos Vig\u00e1rio, F. Vaisman, C.M. Coeli, L. Ward, H. Graf, G. Carvalho, R.M. J\u00fanior, M. Vaisman, Inadequate levothyroxine replacement for primary hypothyroidism is associated with poor health-related quality of life\u2013a Brazilian multicentre study. Endocrine 44(2), 434\u2013440 (2013)","journal-title":"Endocrine"},{"issue":"2","key":"2211_CR35","first-page":"127","volume":"3","author":"M Katz","year":"2010","unstructured":"M. Katz, J. Scherger, S. Conard, L. Montejano, S. Chang, Healthcare costs associated with switching from brand to generic levothyroxine. Am. Health Drug Benefits 3(2), 127\u2013134 (2010)","journal-title":"Am. Health Drug Benefits"},{"issue":"1","key":"2211_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12020-017-1244-2","volume":"56","author":"S Benvenga","year":"2017","unstructured":"S. Benvenga, F. Di Bari, R. Vita, Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine. Endocrine 56(1), 138\u2013145 (2017)","journal-title":"Endocrine"},{"issue":"15","key":"2211_CR37","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1001\/archinte.165.15.1714","volume":"165","author":"A Roos","year":"2005","unstructured":"A. Roos, S.P. Linn-Rasker, R.T. van Domburg, J.P. Tijssen, A. Berghout, The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch. Intern. Med. 165(15), 1714\u20131720 (2005)","journal-title":"Arch. Intern. Med."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02211-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-020-02211-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02211-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:20:02Z","timestamp":1611706802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-020-02211-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["2211"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02211-w","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]},"assertion":[{"value":"28 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"In the past 3 years, RAH has provided expert testimony for Daiichi Sankyo and Takeda. ZW and SKD are employed by the US FDA, Center for Drug Evaluation and Research. No other authors declare a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}